Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of intravenously infused allogeneic umbilical cord-derived mesenchymal stem cells for aging frailty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells, allogeneic (mesenchymal stem cells, allogeneic)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Frailty | Phase 1 | Status: RECRUITING